==== Front Tob Induc Dis Tob Induc Dis TID Tobacco Induced Diseases 2070-7266 1617-9625 European Publishing on behalf of the International Society for the Prevention of Tobacco Induced Diseases (ISPTID) 97 10.18332/tid/130350 Research Paper Associations of intensity, duration, cumulative dose, and age at start of smoking, with thyroid cancer in Chinese males: A hospital-based case–control study in Zhejiang Province Wang Meng 1* Gong Wei W. 1* Lu Feng 1 He Qing F. 1 Hu Ru Y. 1 Zhong Jie M. 1 Yu Min 1 1 Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China CORRESPONDENCE TO Min Yu. Zhejiang Provincial Center for Disease Control and Prevention, 3399 Binsheng Road, Hangzhou 310051, China. E-mail: mycdc1234@163.com* Contributed equally 01 12 2020 2020 18 9704 7 2020 25 10 2020 10 11 2020 © 2020 Wang M. et al.2020This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License.INTRODUCTION There has been considerable research on the association between smoking status and thyroid cancer risk in males, yet the findings are inconsistent. In this study, we investigated the associations of intensity, duration, cumulative dose, and age at start of smoking, with thyroid cancer in Chinese males. METHODS From a 1:1 matched case–control study conducted between 2015 and 2017 in Zhejiang Province, China, 676 pairs of male subjects were included in the analysis. The associations between smoking characteristics and thyroid cancer were evaluated in logistic regression models by odds ratios (ORs) with 95% confidence intervals (CIs). RESULTS Compared with never smokers, the former smokers were 0.096 times (95% CI: 0.012–0.778) less likely to have thyroid cancer. The significant inverse association was not observed in current smokers (OR=0.333; 95% CI: 0.084–1.322). Among both former and current smokers, higher smoking intensity (>10 cigarettes/day), duration (>15 years), and cumulative dose of smoking (>10 packyears) were significantly associated with reduced occurrence of thyroid cancer. CONCLUSIONS Our findings indicate that former smoking is inversely associated with thyroid cancer occurrence in Chinese males. The reduction in the occurrence of thyroid cancer was also confirmed for both former and current smokers with higher smoking intensity, duration, and cumulative dose. thyroid cancersmokingcase–control study ==== Body INTRODUCTION Thyroid cancer incidence has been rising substantially worldwide. From 1990 to 2013, the global age-standardized incidence rate of thyroid cancer increased by 20%1. The overall thyroid cancer incidence in the United States increased 3% annually during 1974 and 20132. In parallel, the incidence of thyroid cancer in South Korea rose by 14 times from 1993 to 20113. Consistently, a significant trend of increasing incidence of thyroid cancer has been found in China in the past decades. Between 2000 and 2011, a dramatic rise in thyroid cancer incidence was observed among the female population in China, with an annual percentage change (APC) of 20.1%4. Meanwhile, the growing trend was confirmed in local Chinese populations in Shanghai, Hong Kong, Taiwan and Zhejiang5-7. According to previous studies, the markedly increasing incidence of thyroid cancer could be explained not only by the improved diagnostic techniques, but also by the elevated prevalence of individual risk factors (e.g. obesity) and exposure to environmental risk factors (e.g. iodine levels)8,9. Tobacco use is the leading preventable cause of cancer worldwide. The World Health Organization (WHO) reported that at least 19 other cancer sites or sub-sites were designated as causally related to smoking10. However, a series of recent pooled analyses with case–control or cohort studies suggested reduced thyroid cancer risk in ever and current smokers, compared with never smokers11,12. Except for the smoking status, increasing studies have further revealed that the reduced risk was more pronounced in smokers with greater smoking intensity, duration and pack-years13,14. Consistent with these findings, mechanistic studies also provided biological plausibility in explaining the possible protective effect of smoking on thyroid cancer. It was widely assumed that the inverse association with thyroid cancer risk was due to lower levels of thyroid stimulating hormone (TSH), thyroid auto-antibodies and the anti-estrogenic effect in smokers15-19. Even so, given the considerable types of smoking-related cancers, further studies in this field are warranted. With 315 million smokers, China is the largest producer and consumer of tobacco20. However, relevant evidence on the role of smoking in thyroid cancer occurrence among the Chinese population is lacking. To fill this knowledge gap, we carried out a hospital-based case–control study in Zhejiang Province to investigate the possible associations between intensity, duration, cumulative dose, and age at start of smoking, with thyroid cancer in Chinese males. METHODS Study subjects To explore the associated factors of thyroid cancer, a 1:1 matched hospital-based case–control study was performed in 7 counties (Lucheng, Pingyang, Cangnan, Cixi, Nanhu, Changxing and Yongkang) of Zhejiang Province. Case subjects were eligible if they were first primary thyroid cancer diagnosed in local hospitals from July 2015 to December 2017. All the thyroid cancer cases were identified by physician review of medical records and pathology reports. Notably, among the cases, those who had a history of any cancer or were unable/unwilling to complete the study questionnaire were excluded. In the current study, thyroid cancer was further identified based on ICD-10 and referred to malignant neoplasm of thyroid gland (C73). In the same area and same year, control subjects were selected from thyroid-healthy examinees who underwent thyroid function tests and thyroid ultrasound screening in the annual routine physical examination, which was conducted in local hospitals. In Zhejiang Province, authorized by the government, fixed local hospitals organize physical examination covering all the insured residents in community or village once a year. We excluded subjects with abnormal levels of free triiodothyronine, free thyroxine, and TSH, respectively. Besides, we excluded those whose ultrasound findings showed suspected malignancy. Control subjects who had a history of any cancer or were unable/unwilling to complete the study questionnaire were also excluded. Finally, case subjects were matched to control subjects by age (plus or minus three years) and sex. Estimation of the sample size In our study, the cases and controls were selected by 1:1, so we calculated the sample size from the following formulae: M=mp0q1+p1q0 m=[Uα/2+Uβ(p(1−p))]2/(p−1/2)2 p=OR1+OR≅RR1+RR With p1=p0OR1+p0(OR−1) And q1=1−p1,q0=1−p0 where p0 is the estimated diabetes exposure rate in the control group, p1 is the estimated diabetes exposure rate in the case group, with values p0 = 0.07, OR = 2, α = 0.05, β = 0.10, so that the sample size M = 398 in each county, and actually 2937 pairs of subjects were recruited in 7 counties. Questionnaire With a designed questionnaire, the interviewer collected all relevant information face-to-face at enrollment. The questionnaire was completed within two months after each pair of case and control was successfully matched. The questionnaire design went through literature review, panel discussion, check and approval by experts and revision after pilot study. The same structured questionnaire was administered to each pair of subjects by the same trained interviewer. The questionnaire was used to collect information on sociodemographic characteristics, individual history and family history of chronic diseases, lifestyle behaviors, environmental hazardous substances exposure, and dietary habits, etc. The specific content of the questionnaire has been described in detail elsewhere21, and is thus only briefly described here. This study was carried out in accordance with the Declaration of Helsinki 1975, and verbal consents were obtained from participants and approved by the Ethics Committee of Zhejiang Provincial Center for Disease Control and Prevention (CDC). The ethics committee approved the procedure for verbal consent because Zhejiang CDC has the authority of the Zhejiang provincial government to collect and publish the cancer related information, which is part of disease surveillance scope in Zhejiang CDC. All the participants (cases and controls) were notified that they have the right to refuse or terminate the study at any point of the interview. Because we obtained verbal consent, documentation of consent was not required. However, the information provided by each participant was kept confidential in Zhejiang CDC. Definition of smoking variables Information on smoking status, intensity, duration, and age at start of smoking, was collected via the designed questionnaire at enrollment. Smoking status was grouped as never, former, and current. Former smokers were defined as subjects who have quitted smoking at least 1 year. Current smokers were defined as subjects who smoked currently or daily. Smoking intensity was defined as the average number of cigarettes smoked per day and dichotomized as ≤10 and >10 cigarettes. Duration of smoking was defined as the total smoking years reported by the former and current smokers and dichotomized as ≤15 and >15 years. The cumulative dose of smoking was calculated as pack-years (the number of cigarettes smoked per day divided by 20 [assuming 20 cigarettes per pack] and multiplied by the duration of smoking years). We dichotomized pack-years as ≤10 and >10. The variable, age at start of smoking (dichotomized as ≤20 and >20 years) was also included in the analysis. All smoking variables were grouped to be as consistent, as possible, with previously published studies on this topic, based on the sample sizes in each group. Definition of the covariates The following variables were collected at enrollment and chosen as the potential confounders. Age (≤40 and >40 years), marriage status (unmarried, married), education level (no formal/primary school, middle/high school, college/university/postgraduate), average monthly household income (≤2000; 2000–5000; >5000 RMB; with 1000 Chinese Renminbi about 150 US$), alcohol drinking (never, occasional, current regular), body mass index (underweight, normal weight, overweight, obese), family history of thyroid cancer (negative, positive) were included in the analyses. The body mass index (BMI: kg/m2) was calculated as weight divided by the square of height. According to the Chinese adult BMI classification proposed by the Working Group on Obesity in China in 200122, subjects were categorized as underweight (<18.5), normal weight (18.5–23.9), overweight (24.0–27.9), or obese (≥28.0). Statistical analysis Descriptive statistics were used to describe the baseline characteristics of male subjects with frequency (n) and proportion (%). Univariate conditional logistic regression models were performed to examine the relationships of the covariates with the thyroid cancer. To examine the associations between smoking status, intensity, duration, cumulative dose, and age at start of smoking, with thyroid cancer, we conducted four multivariable conditional logistic regression models to adjust for the covariates and the possible effects, by calculating odds ratios (ORs) and 95% confidence intervals (CIs). The intensity, duration, cumulative dose, and age at start of smoking, were analyzed in combination with smoking status for former and current smokers. In Model 1, only age was adjusted. In Model 2, age and other sociodemographic characteristics including education level, average monthly household income, marriage status, and family history of thyroid cancer were included. Model 3 adjusted as for Model 2 plus the health behavior of alcohol intake. Model 4 adjusted as for Model 3 plus BMI. Subgroup analyses were performed stratified by age (≤40 and >40 years), BMI (normal/underweight, obese/overweight), and alcohol intake (non-drinker, drinker) in multivariable logistic regression models; only the final results (Model 4) are presented. All analyses were based on the two-sided 5% level of significance and performed using SAS statistical package (version 9.2, SAS Institute, Inc., Cary, NC, USA). RESULTS Baseline characteristics of subjects A total of 2937 pairs of subjects participated in the case–control study. Among them, there were 2261 pairs (77.0%) of females and 676 pairs (23.0%) of males. Considering the extremely low prevalence of smoking in females (former and current, 0.42%), we only included the male subjects in the present analysis. The mean (SD) age in male case and control subjects was 48.71 (1.29) years and 48.61 (1.29) years, respectively. Of the 1352 males, there were 175 former smokers (12.94%) and 587 current smokers (43.42%). Frequencies and proportions of baseline characteristics among case and control subjects are shown in Table 1. Compared to control subjects, case subjects were more likely to have higher education (college/university/postgraduate, p=0.016), be overweight (p<0.001) or obese (p=0.041), and less likely to drink alcohol occasionally (p=0.001) and current regularly (p<0.001). Table 1 The baseline characteristics of male subjects and their relationships with thyroid cancer Factors Cases (N=676) n (%) Controls (N=676) n (%) p OR 95 % CI Age (years), mean±SD 48.71±1.29 48.61±1.29 >40 489 (72.34) 491 (72.63) ≤40 187 (27.66) 185 (27.37) Education level No formal/primary school 169 (25.00) 178 (26.33) Ref. Middle/high school 318 (47.04) 346 (51.18) 0.672 1.073 0.774–1.488 College/university/postgraduate 187 (27.66) 150 (22.19) 0.016 1.701 1.105–2.619 Marriage status Unmarried 50 (8.14) 49 (7.25) Ref. Married 621 (91.86) 626 (92.60) 0.893 0.964 0.568–1.636 Average monthly household income (RMB) ≤2000 481 (71.15) 462 (68.34) Ref. 2000–5000 72 (10.65) 81 (11.99) 0.208 0.776 0.523–1.152 >5000 123 (18.20) 133 (19.67) 0.201 0.786 0.544–1.137 Body mass index Normal weight 296 (43.79) 377 (55.77) Ref. Underweight 12 (1.78) 19 (2.81) 0.599 0.813 0.376–1.758 Overweight 277 (40.98) 223 (32.99) <0.001 1.704 1.324–2.193 Obese 66 (9.76) 56 (8.28) 0.041 1.523 1.018–2.279 Family history of thyroid cancer Negative 17 (2.51) 3 (0.44) Ref. Positive 127 (18.79) 106 (15.68) 0.341 3.000 0.312–28.841 Alcohol drinking Never 331 (48.96) 237 (35.06) Ref. Occasional 205 (30.33) 221 (32.69) 0.001 0.624 0.470–0.828 Current regular 140 (20.71) 218 (32.25) <0.001 0.417 0.309–0.562 OR: odds ratio. CI: confidence interval. Ref.: reference. Percentages of each variable may not add up to 100% because of missing data or rounding off. RMB: 1000 Chinese Renminbi about 150 US$. The associations between smoking characteristics and thyroid cancer Table 2 shows the results of multivariable models investigating the associations between smoking status, intensity, duration, cumulative dose, and age at start of smoking, with thyroid cancer (see also Supplementary file). In Model 1, compared with never smokers, the former smokers were 1.619 times (95% CI: 1.115–2.351) more likely to have thyroid cancer, after adjusting for age. The consistent effects were also found among former smokers with higher intensity (>10 cigarettes/day), shorter duration (≤15 years), lower cumulative dose of smoking (≤10 packyears) and later age at start of smoking (>20 years), with an OR of 1.717 (95% CI: 1.085–2.716), 1.986 (95% CI: 1.105–3.571), 1.762 (95% CI: 1.014–3.061), and 1.748 (95% CI: 1.075–2.844), respectively. With further adjustment for other sociodemographic characteristics and health behavior of alcohol in Models 2 and 3, these effects of smoking on thyroid cancer were largely inversed and attenuated to zero. However, after adjustment for the BMI in Model 4, a reduced occurrence of thyroid cancer was observed in former and current smokers with different smoking characteristics. Compared with never smokers, the former smokers were 0.096 times (95% CI: 0.012–0.778) less likely to have thyroid cancer. Consistent in both former and current smokers, higher intensity (>10 cigarettes/day), higher duration (>15 years), and higher cumulative dose of smoking (>10 packyears) were significantly associated with reduced occurrence of thyroid cancer. Subgroup analyses showed that the associations between smoking status, intensity, duration, cumulative dose, age at start of smoking, and thyroid cancer were modified by age, BMI and alcohol intake, although no interactions were observed with any of the variables. Table 2 Multivariate analyses – associations between smoking status, as well as intensity, duration, cumulative dose and age at start of smoking with thyroid cancer in males Factors Cases (N=676) Controls (N=676) Model 1 Model 2 Model 3 Model 4 OR† 95% CI OR† 95% CI OR† 95% CI OR† 95 % CI Smoking status Never smoker 294 296 Ref. Ref. Ref. Ref. Former smoker 106 69 1.619 1.115–2.351 0.214 0.044–1.042 0.251 0.047–1.342 0.096 0.012–0.778 Current smoker 276 311 0.890 0.692–1.145 0.571 0.186–1.749 0.622 0.194–1.996 0.333 0.084–1.322 Intensity of smoking (cigarettes/day) Never smoker 294 296 Ref. Ref. Ref. Ref. ≤10 FS 41 29 1.471 0.865–2.503 0.163 0.019–1.407 0.143 0.014–1.476 0.086 0.006–1.228 >10 FS 65 40 1.717 1.085–2.716 0.160 0.021–1.248 0.182 0.019–1.727 0.045 0.003–0.802 ≤10 CS 112 123 0.917 0.671–1.254 1.129 0.296–4.306 1.227 0.307–4.897 0.601 0.110–3.296 >10 CS 164 188 0.866 0.640–1.172 0.215 0.043–1.071 0.230 0.044–1.203 0.131 0.020–0.847 Duration of smoking (years) Never smoker 294 296 Ref. Ref. Ref. Ref. ≤15 FS 36 18 1.986 1.105–3.571 0.445 0.063–3.139 0.495 0.059–4.160 0.132 0.007–2.358 >15 FS 70 51 1.487 0.960–2.302 0.064 0.005–0.791 0.089 0.007–1.151 0.013 0.001–0.378 ≤15 CS 58 71 0.798 0.531–1.200 1.161 0.140–9.650 1.176 0.138–9.995 1.590 0.154–16.379 >15 CS 218 240 0.928 0.700–1.232 0.437 0.114–1.679 0.475 0.120–1.886 0.129 0.018–0.917 Cumulative dose of smoking (packyears) Never smoker 294 296 Ref. Ref. Ref. Ref. ≤10 FS 39 22 1.762 1.014–3.061 0.211 0.025–1.775 0.228 0.024–2.159 0.097 0.007–1.444 >10 FS 67 47 1.491 0.950–2.340 0.158 0.020–1.282 0.188 0.021–1.726 0.044 0.002–0.784 ≤10 CS 92 92 0.981 0.697–1.381 2.531 0.365–17.529 2.333 0.325–16.755 1.386 0.161–11.928 >10 CS 184 219 0.835 0.625–1.115 0.337 0.090–1.269 0.367 0.093–1.446 0.172 0.033–0.892 Age started smoking (years) Never smoker 294 296 Ref. Ref. Ref. Ref. ≤20 FS 54 39 1.497 0.919–2.439 0.217 0.031–1.514 0.239 0.031–1.850 0.096 0.008–1.111 >20 FS 52 30 1.748 1.075–2.844 0.216 0.029–1.585 0.269 0.034–2.133 0.100 0.008–1.209 ≤20 CS 145 163 0.894 0.661–1.210 0.634 0.192–2.086 0.699 0.204–2.388 0.351 0.080–1.529 >20 CS 131 148 0.885 0.648–1.209 0.441 0.098–1.987 0.468 0.097–2.262 0.302 0.053–1.724 FS: former smoker. CS: current smoker. OR: odds ratio. CI: confidence interval. Ref.: reference. Bold numbers represent significant results. † Model 1 only adjusted for age; Model 2 adjusted as for Model 1 plus sociodemographic characteristics including education level, average monthly household income, marriage status, and family history of thyroid cancer; Model 3 adjusted as for Model 2 plus the health behavior of alcohol intake; Model 4 adjusted as for Model 3 plus BMI. DISCUSSION Overall, findings from this study indicate an inverse association between former versus never smoking and thyroid cancer occurrence in Chinese males, while this was not statistically significant in current smokers after adjustment for potential confounders. In combination with different measures of smoking characteristics, our results further confirmed that higher smoking intensity, duration, and cumulative dose were significantly associated with reduced thyroid cancer occurrence among both former and current smokers. However, when stratified by age, BMI and alcohol intake, these observed associations were attenuated to zero. The present study is probably one of the few studies attempting to investigate the role of smoking in thyroid cancer occurrence in the Chinese population. There has been considerable research on the association between smoking status and thyroid cancer risk in males, yet the findings are inconsistent. Specifically, a pooled analysis of 14 case–control studies conducted in 2003 indicated that former smoking was associated with decreased thyroid cancer risk, while the effect was not pronounced (OR=0.9; 95% CI: 0.6–1.3)14. The lower risk of thyroid cancer among former smokers was confirmed in a recent cohort study, and similarly, this association did not reach statistical significance (HR=0.90; 95% CI: 0.71–1.14)23. In addition, another pooled analysis of five prospective studies in the United States reported a non-significant positive association between former smoking and thyroid cancer risk (OR=1.10; 95% CI: 0.86–1.40)13. In our study, although findings were consistent with the literature, where studies have reported reduced risk associated with former smoking, it is noteworthy that our observed effect was statistically significant (OR=0.096; 95% CI: 0.012–0.778). Regarding current smoking, we showed a non-significant inverse association with thyroid cancer in males (OR=0.333; 95% CI: 0.084–1.322), which was in accord with findings from two independent pooled analysis of case–control (OR=0.7; 95% CI: 0.5–1.0) and prospective studies (OR=0.83; 95% CI: 0.55–1.24)13,14. The possible decreased risk of thyroid cancer in current smokers was further confirmed in a large cohort study where a significant association was reported (HR=0.56; 95% CI: 0.43–0.72)23. Besides, a non-significant positive association between current smoking and thyroid cancer (OR=1.36; 95% CI: 0.44–4.26) was also found in a countrywide case–control study in New Caledonia24. Similar to the smoking status, the relationships between other smoking characteristics and thyroid cancer risk seemed to be inconclusive as well. In our study, the results showed that higher smoking intensity, duration, and cumulative dose were significantly associated with reduced thyroid cancer occurrence in males, which were well confirmed in a Canadian case–control study25. In another case–control study in the United States, greater smoking intensity but not duration was found to be associated with a lower risk of thyroid cancer26. Our finding on the cumulative dose of smoking was also consistent with result from a recent Korean cohort study, where a dose-dependent inverse association between smoking pack-years and thyroid cancer risk was reported23. Besides, according to a case–control study in Serbia, the authors found that neither smoking intensity nor duration was significantly associated with thyroid cancer in men27. In theory, the varied effects on thyroid cancer risk reported by these studies could be due to the differences in sample size, study design, population characteristics, and measures of smoking exposures. In addition, when stratified by age, BMI and alcohol intake, we found that the significant associations between smoking characteristics and thyroid cancer were attenuated to zero, which may be due to the small number of cases in each subgroup. Possible biological mechanisms linking the reduced risk of thyroid cancer and smoking have been studied and hypothesized to rely on the low levels of TSH, thyroid auto-antibodies, and anti-estrogenic effect in smokers15-19. Other chemical constituents of cigarettes such as nicotine and anatabine may also play a contributory role28,29, which requires further confirmation in mechanistic studies. Besides, we speculated that the difference in the risk of thyroid cancer between former and current smokers was due to the ‘sick-quitter effect’. Specifically, the former smokers might be inspired to abstain due to health problems such as diabetes; based on prior knowledge30,31, the risk of thyroid cancer in diabetes patients is much lower, possibly due to the effects of diabetes drugs (e.g. metformin). Strengths and limitations Our study had several strengths. This is one of the few studies investigating the role of smoking in thyroid cancer occurrence among the Chinese population. In the hospital-based case–control study, all incident thyroid cancer cases were diagnosed in hospitals and further identified by physician review of medical records and pathology reports, which would minimize the probability of misclassification. However, some limitations were also observed. First, only males were included in the study and the relatively small number of subjects could limit the statistical power to investigate the associations between smoking characteristics and thyroid cancer. Second, with a retrospective design and self-reported smoking characteristics, recall bias may be inevitable in this study. Third, the information of years since quitting smoking was not collected at baseline, limiting our ability to evaluate the effect of former smoking on thyroid cancer. CONCLUSIONS Findings from the present case–control study indicate that former smoking is inversely associated with thyroid cancer occurrence in Chinese males. The reductions in occurrence were also confirmed in both former and current smokers with higher smoking intensity, duration, and cumulative dose. Supplementary Material Click here for additional data file. ACKNOWLEDGEMENTS We thank for their important contributions all colleagues at hospitals, health services centers and CDCs that participated in the study. CONFLICTS OF INTEREST The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none was reported. FUNDING This work was supported by a grant from the National Key Research and Development Program of China ‘Precision Medical Research’ (2016YFC0900502) of the Ministry of Science and Technology; and a grant from the Zhejiang Medical and Health Technology Project (2021KY614). PROVENANCE AND PEER REVIEW Not commissioned; externally peer reviewed. ==== Refs REFERENCES Global Burden of Disease Cancer Collaboration The Global Burden of Cancer 2013 JAMA Oncol 2015 1 505 527 10.1001/jamaoncol.2015.0735 26181261 Lim H Devesa SS Sosa JA Check D Kitahara CM Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013 JAMA 2017 317 1338 1348 10.1001/jama.2017.2719 28362912 Ahn HS Kim HJ Welch HG Korea's thyroid-cancer ‘epidemic’--screening and overdiagnosis N Engl J Med 2014 371 1765 1767 10.1056/NEJMp1409841 25372084 Chen W Zheng R Baade PD Cancer statistics in China, 2015 CA Cancer J Clin 2016 66 115 132 10.3322/caac.21338 26808342 Xie SH Chen J Zhang B Time trends and age-period-cohort analyses on incidence rates of thyroid cancer in Shanghai and Hong Kong BMC Cancer 2014 14 975 10.1186/1471-2407-14-975 25519305 Liu FC Lin HT Lin SF Kuo CF Chung TT Yu HP Nationwide cohort study on the epidemiology and survival outcomes of thyroid cancer Oncotarget 2017 8 78429 78451 10.18632/oncotarget.19488 29108240 Du L Wang Y Sun X Thyroid cancer: trends in incidence, mortality and clinical-pathological patterns in Zhejiang Province, Southeast China BMC Cancer 2018 18 291 10.1186/s12885-018-4081-7 29544469 Kim J Gosnell JE Roman SA Geographic influences in the global rise of thyroid cancer Nat Rev Endocrinol 2020 16 17 29 10.1038/s41574-019-0263-x 31616074 Wiltshire JJ Drake TM Uttley L Balasubramanian SP Systematic Review of Trends in the Incidence Rates of Thyroid Cancer Thyroid 2016 26 1541 1552 10.1089/thy.2016.0100 27571228 World Health Organization The Cancer Atlas 2019 3rd ed Atlanta, GA American Cancer Society https://canceratlas.cancer.org/wp-content/uploads/2019/10/ACS_CA3_Book.pdf . Accessed June 4, 2020 Cho YA Kim J Thyroid cancer risk and smoking status: a meta-analysis Cancer Causes Control 2014 25 1187 1195 10.1007/s10552-014-0422-2 24981099 Tsekouras V Smoking, alcohol and thyroid cancer occurrence: systematic review and meta-analysis of case-control studies Expert Rev Endocrinol Metab 2013 8 505 515 10.1586/17446651.2013.856137 30736135 Kitahara CM Linet MS Beane Freeman LE Cigarette smoking, alcohol intake, and thyroid cancer risk: a pooled analysis of five prospective studies in the United States Cancer Causes Control 2012 23 1615 1624 10.1007/s10552-012-0039-2 22843022 Mack WJ Preston-Martin S Dal Maso L A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea Cancer Causes Control 2003 14 773 785 10.1023/a:1026349702909 14674742 Belin RM Astor BC Powe NR Ladenson PW Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III) J Clin Endocrinol Metab 2004 89 6077 6086 10.1210/jc.2004-0431 15579761 Soldin OP Goughenour BE Gilbert SZ Landy HJ Soldin SJ Thyroid hormone levels associated with active and passive cigarette smoking Thyroid 2009 19 817 823 10.1089/thy.2009.0023 19505184 Asvold BO Bjøro T Nilsen TI Vatten LJ Tobacco smoking and thyroid function: a population-based study Arch Intern Med 2007 167 1428 1432 10.1001/archinte.167.13.1428 17620538 Jorde R Sundsfjord J. Serum TSH levels in smokers and non-smokers. The 5th Tromsø study Exp Clin Endocrinol Diabetes 2006 114 343 347 10.1055/s-2006-924264 16915535 Shiels MS Rohrmann S Menke A Association of cigarette smoking, alcohol consumption, and physical activity with sex steroid hormone levels in US men Cancer Causes Control 2009 20 877 886 10.1007/s10552-009-9318-y 19277882 World Health Organization WHO report on the global tobacco epidemic, 2017: monitoring tobacco use and prevention policies 2017 Geneva World Health Organization https://apps.who.int/iris/bitstream/handle/10665/255874/9789241512824-eng.pdf;jsessionid=95ACF79EFDE34633785DD8DA7ED026AB?sequence=1 . Accessed June 4, 2020 Lu F Ying DN Gong WW Factors related to thyroid carcinoma in Zhejiang province: a matched case-control study Zhonghua Liu Xing Bing Xue Za Zhi 2018 39 1387 1393 10.3760/cma.j.issn.0254-6450.2018.10.018 30453442 Zhou B. Cooperative Meta-Analysis Group of China Obesity Task Force. Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population Zhonghua Liu Xing Bing Xue Za Zhi 2002 23 5 10 12015100 Cho A Chang Y Ahn J Shin H Ryu S Cigarette smoking and thyroid cancer risk: a cohort study Br J Cancer 2018 119 638 645 10.1038/s41416-018-0224-5 30111870 Guignard R Truong T Rougier Y Baron-Dubourdieu D Guénel P Alcohol drinking, tobacco smoking, and anthropometric characteristics as risk factors for thyroid cancer: a countrywide case-control study in New Caledonia Am J Epidemiol 2007 166 1140 1149 10.1093/aje/kwm204 17855390 Kreiger N Parkes R Cigarette smoking and the risk of thyroid cancer Eur J Cancer 2000 36 1969 1973 10.1016/s0959-8049(00)00198-2 11000579 Meinhold CL Ron E Schonfeld SJ Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study Am J Epidemiol 2010 171 242 252 10.1093/aje/kwp354 19951937 Zivaljevic V Slijepcevic N Sipetic S Risk factors for well-differentiated thyroid cancer in men Tumori 2013 99 458 462 10.1700/1361.15094 24326832 Wiersinga WM Smoking and thyroid Clin Endocrinol (Oxf) 2013 79 145 151 10.1111/cen.12222 23581474 Caturegli P De Remigis A Ferlito M Anatabine ameliorates experimental autoimmune thyroiditis Endocrinology 2012 153 4580 4587 10.1210/en.2012-1452 22807490 Cho YY Kang MJ Kim SK Protective Effect of Metformin Against Thyroid Cancer Development: A Population-Based Study in Korea Thyroid 2018 28 864 870 10.1089/thy.2017.0550 29808777 Tseng CH Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes PLoS One 2014 9 e109852 10.1371/journal.pone.0109852 25303400